# Bluepha

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bluepha

- Industry: Biopolymers
- Headquarters: Beijing, China
- Website: www.bluepha.com
- Total disclosed funding: $298M
- Latest round: Series B (Feb 14, 2023)
- Investors on record: 19

## About

Founded in 2016 and based in Beijing, China, Bluepha is a biotechnology company that focuses on the development of bio-based molecules and materials, with R&D centers and offices in Shenzhen, Shanghai, and Jiangsu. As of February 2023, it has completed a total of nearly RMB 1.5 billion in financing. The co-founder and CEO, Haoqian Zhang graduated from Beijing University.

The company engages in the development of bio-based molecules and materials. Its main products include PHA, a biological material that is completely degraded spontaneously, functional drink ingredients that relieve anxiety, new functional probiotics that compensate for common metabolic defects in the human body, etc. Their products can be used in consumer products, healthcare, agricultural environmental protection, and electronic and electrical industries.

## Funding rounds

- Series B, Feb 14, 2023, $58M — Jiangsu Huanghai Financial Holding Group, Zhongping Capital
- Series B, Jan 10, 2022, $136M — Frees Fund, Genesis Capital, Zhongzhou Lanhai Investment Management, GL Ventures, Shenzhen Country Garden Venture Capital Co., Ltd., Trinity Innovation Fund, Mixed Reform Fund, Jiangsu Huanghai Financial Holding Group, Zhongping Capital
- Series B, Aug 9, 2021, $66M — Lightspeed Venture Partners, China Renaissance, Frees Fund, Septwolves Holding, TH Capital, Qianhai Ark Capital, Fangyuan Rongtong Fund, Qihang Capital, GL Ventures, Shenzhen Country Garden Venture Capital Co., Ltd., Trinity Innovation Fund
- Series B, Feb 26, 2021, $31M — Lightspeed Venture Partners, Frees Fund, Septwolves Holding, Qianhai Ark Capital, Zhongfa Advanced Capital, Qihang Capital, GL Ventures, Trinity Innovation Fund
- Series A, May 27, 2020 — Green Pine Capital Partners
- Series A, Nov 15, 2019, $5.7M — Frees Fund, Qianhai Ark Capital, Zhongguancun Development Venture

## Investors

- Frees Fund (https://capitalatlas.ai/funds/frees-fund) — Series A, Series B
- Qianhai Ark Capital (https://capitalatlas.ai/funds/qianhai-ark-capital) — Series A, Series B
- Zhongguancun Development Venture (https://capitalatlas.ai/funds/zhongguancun-development-venture) — Series A
- Green Pine Capital Partners (https://capitalatlas.ai/funds/green-pine-capital-partners) — Series A
- Lightspeed Venture Partners (https://capitalatlas.ai/funds/lightspeed-venture-partners) — Series B
- Septwolves Holding (https://capitalatlas.ai/funds/septwolves-holding) — Series B
- Zhongfa Advanced Capital (https://capitalatlas.ai/funds/zhongfa-advanced-capital) — Series B
- Qihang Capital (https://capitalatlas.ai/funds/qihang-capital) — Series B
- GL Ventures (https://capitalatlas.ai/funds/gl-ventures) — Series B
- Trinity Innovation Fund (https://capitalatlas.ai/funds/trinity-innovation-fund) — Series B
- China Renaissance (https://capitalatlas.ai/funds/china-renaissance) — Series B
- TH Capital (https://capitalatlas.ai/funds/th-capital) — Series B
- Fangyuan Rongtong Fund (https://capitalatlas.ai/funds/fangyuan-rongtong-fund) — Series B
- Shenzhen Country Garden Venture Capital Co., Ltd. — Series B
- Genesis Capital — Series B
- Zhongzhou Lanhai Investment Management (https://capitalatlas.ai/funds/zhongzhou-lanhai-investment-management) — Series B
- Mixed Reform Fund — Series B
- Jiangsu Huanghai Financial Holding Group — Series B
- Zhongping Capital (https://capitalatlas.ai/funds/zhongping-capital) — Series B